These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9234314)
1. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Shah F; Hume SP; Pike VW; Ashworth S; McDermott J Nucl Med Biol; 1994 May; 21(4):573-81. PubMed ID: 9234314 [TBL] [Abstract][Full Text] [Related]
2. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270 [TBL] [Abstract][Full Text] [Related]
3. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites--current status. Pike VW; Halldin C; Crouzel C; Barré L; Nutt DJ; Osman S; Shah F; Turton DR; Waters SL Nucl Med Biol; 1993 May; 20(4):503-25. PubMed ID: 8389223 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Hashimoto K; Inoue O; Suzuki K; Yamasaki T; Kojima M Ann Nucl Med; 1989 Jul; 3(2):63-71. PubMed ID: 2561896 [TBL] [Abstract][Full Text] [Related]
5. Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors. Matarrese M; Moresco RM; Cappelli A; Anzini M; Vomero S; Simonelli P; Verza E; Magni F; Sudati F; Soloviev D; Todde S; Carpinelli A; Kienle MG; Fazio F J Med Chem; 2001 Feb; 44(4):579-85. PubMed ID: 11170647 [TBL] [Abstract][Full Text] [Related]
6. Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies. Pomper MG; Musachio JL; Scheffel U; Macdonald JE; McCarthy DJ; Reif DW; Villemagne VL; Yokoi F; Dannals RF; Wong DF J Nucl Med; 2000 Aug; 41(8):1417-25. PubMed ID: 10945536 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 11C-labeled nonpeptide antagonists for cholecystokinin receptors: [11C]L-365,260 and [11C]L-365,346. Haradahira T; Inoue O; Kobayashi K; Suzuki K Nucl Med Biol; 1998 Apr; 25(3):203-8. PubMed ID: 9620624 [TBL] [Abstract][Full Text] [Related]
8. Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. Petit-Taboué MC; Baron JC; Barré L; Travère JM; Speckel D; Camsonne R; MacKenzie ET Eur J Pharmacol; 1991 Aug; 200(2-3):347-51. PubMed ID: 1782994 [TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors. Sekimata K; Hatano K; Ogawa M; Abe J; Magata Y; Biggio G; Serra M; Laquintana V; Denora N; Latrofa A; Trapani G; Liso G; Ito K Nucl Med Biol; 2008 Apr; 35(3):327-34. PubMed ID: 18355688 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[11C]dimethyl-3-(2',4'-dichlorophenyl)-indanamine (cis-[11C]DDPI). Suehiro M; Scheffel U; Dannals RF; Wilson AA; Ravert HT; Wagner HN Int J Rad Appl Instrum B; 1992 Jul; 19(5):549-53. PubMed ID: 1399685 [TBL] [Abstract][Full Text] [Related]
11. In vivo biodistribution of [N-11C-methyl]KF 17837 using 3-D-PET: evaluation as a ligand for the study of adenosine A2A receptors. Stone-Elander S; Thorell JO; Eriksson L; Fredholm BB; Ingvar M Nucl Med Biol; 1997 Feb; 24(2):187-91. PubMed ID: 9089711 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Ding YS; Lin KS; Garza V; Carter P; Alexoff D; Logan J; Shea C; Xu Y; King P Synapse; 2003 Dec; 50(4):345-52. PubMed ID: 14556239 [TBL] [Abstract][Full Text] [Related]
13. Brain kinetics of (R)- and (S)-[N-methyl-11C]ketamine in the rhesus monkey studied by positron emission tomography (PET). Hartvig P; Valtysson J; Antoni G; Westerberg G; Långström B; Ratti Moberg E; Oye I Nucl Med Biol; 1994 Oct; 21(7):927-34. PubMed ID: 9234346 [TBL] [Abstract][Full Text] [Related]
14. [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. Suehiro M; Scheffel U; Ravert HT; Dannals RF; Wagner HN Life Sci; 1993; 53(11):883-92. PubMed ID: 8366755 [TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography of 5-HT transporter sites in the baboon brain with [11C]McN5652. Szabo Z; Scheffel U; Suehiro M; Dannals RF; Kim SE; Ravert HT; Ricaurte GA; Wagner HN J Cereb Blood Flow Metab; 1995 Sep; 15(5):798-805. PubMed ID: 7673372 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors. Cappelli A; Matarrese M; Moresco RM; Valenti S; Anzini M; Vomero S; Turolla EA; Belloli S; Simonelli P; Filannino MA; Lecchi M; Fazio F Bioorg Med Chem; 2006 Jun; 14(12):4055-66. PubMed ID: 16495062 [TBL] [Abstract][Full Text] [Related]
17. Novel irreversible ligands specific for "peripheral" type benzodiazepine receptors: (+/-)-, (+)-, and (-)-1-(2-chlorophenyl)-N-(1-methylpropyl)-N- (2-isothiocyanatoethyl)-3-isoquinolinecarboxamide and 1-(2-isothiocyanatoethyl)-7-chloro-1,3-dihydro-5-(4-chlorophenyl )-2H-1,4-benzodiazepin-2-one. Newman AH; Lueddens HW; Skolnick P; Rice KC J Med Chem; 1987 Oct; 30(10):1901-5. PubMed ID: 2821259 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites. Hume SP; Lammertsma AA; Bench CJ; Pike VW; Pascali C; Cremer JE; Dolan RJ Int J Rad Appl Instrum B; 1992 Nov; 19(8):851-5. PubMed ID: 1428913 [TBL] [Abstract][Full Text] [Related]
19. Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative. Dubroeucq MC; Bénavidès J; Doble A; Guilloux F; Allam D; Vaucher N; Bertrand P; Guérémy C; Renault C; Uzan A Eur J Pharmacol; 1986 Sep; 128(3):269-72. PubMed ID: 3024996 [TBL] [Abstract][Full Text] [Related]
20. PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. Pappata S; Cornu P; Samson Y; Prenant C; Benavides J; Scatton B; Crouzel C; Hauw JJ; Syrota A J Nucl Med; 1991 Aug; 32(8):1608-10. PubMed ID: 1651383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]